Management of Superior Vena Cava Obstruction

Initial Assessment and Management

The American College of Cardiology recommends elevating the patient's head to decrease hydrostatic pressure and cerebral edema in patients with superior vena cava obstruction (SVCO) 1, 2
Consider loop diuretics if cerebral edema is severe in patients with SVCO 1
Systemic corticosteroids may be administered to relieve swelling in patients with SVCO, though evidence for their efficacy is limited 1

Obtain histologic diagnosis before initiating definitive treatment whenever possible in patients with SVCO 1
Biopsy should precede radiation therapy or corticosteroid administration as these may obscure histologic diagnosis in patients with SVCO 1
Color Doppler ultrasound can evaluate flow patterns in accessible veins in patients with SVCO 2

For Small Cell Lung Cancer (SCLC): Chemotherapy is the first-line treatment (response rate ~59%) 1
For Non-Small Cell Lung Cancer (NSCLC): Radiation therapy and/or stent insertion (response rate for radiation ~63%) 1
Stenting is recommended for patients who fail to respond to chemotherapy or radiation therapy 1
Anticoagulation is reasonable for documented acute venous thrombus associated with a central venous catheter (CVL) if no contraindications exist, as recommended by the American Heart Association 3

Monitor for changes in facial, neck, breast, or upper extremity swelling in patients with SVCO 4
Assess for worsening dyspnea, which may indicate progression of obstruction in patients with SVCO 4
Evaluate headache severity to detect potential cerebral venous hypertension in patients with SVCO 4
Use periodic imaging to assess stent patency and position in patients with stents 4

Development of stridor or severe respiratory distress requires immediate intervention in patients with SVCO 4, 2
Signs of cerebral edema including confusion, altered mental status, or coma require immediate intervention in patients with SVCO 4, 2

Recurrence rate after stenting is approximately 11% in patients with SVCO 1
Relapse rates after chemotherapy and/or radiation therapy are seen in approximately 19% of patients with NSCLC 1
Mortality directly from SVCO itself is rare 1